John Wang
- Cancer Research top 10%
- Oncology top 10%
- Cancer-related Molecular Pathways 6
- Internal Medicine top 10%
-
- Prostate Cancer Diagnosis and Treatment 5
- Gastric Cancer Management and Outcomes 4
- Epidemiology top 10%
- Hepatitis B Virus Studies 5
- Neuroendocrine Tumor Research Advances 4
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- RNA modifications and cancer 4
-
- Pancreatic function and diabetes 4
John Wang
76 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 221
- Oncology 314
- Internal Medicine 39
- Pulmonary and Respiratory Medicine 292
- Epidemiology 287
Countries citing papers authored by John Wang
This map shows the geographic impact of John Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wang more than expected).
Fields of papers citing papers by John Wang
This network shows the impact of papers produced by John Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wang. The network helps show where John Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 11 | |
| 9 | 2020 | 8 | |
| 10 | 2019 | 12 | |
| 11 | 2019 | 6 | |
| 12 | 2017 | 12 | |
| 13 | 2011 | 55 | |
| 14 | 2011 | 88 | |
| 15 | 2011 | 15 | |
| 16 | 2010 | 117 | |
| 17 | 2009 | 3 | |
| 18 | 2009 | 3 | |
| 19 | 2007 | 112 | |
| 20 | 2007 | 31 |
About John Wang
John Wang is a scholar working on Oncology, Medical Laboratory Technology and Epidemiology, having authored 81 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (5 papers), Gastric Cancer Management and Outcomes (4 papers), Neuroendocrine Tumor Research Advances (4 papers), RNA modifications and cancer (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Cancer Research (221 citations), Oncology (314 citations) and Internal Medicine (39 citations). John Wang has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Ya‐Wen Cheng, Chih‐Yi Chen, De‐Wei Wu, Julian Lin, Michael D. Tarantino, William C. Hanigan, Huei Lee, Huei Lee, Kun-Tu Yeh and Mei‐Chin Wen. Their work appears in journals such as Clinical Cancer Research, Nature Communications, Bioorganic & Medicinal Chemistry Letters, Cancer Research and Journal of Ultrasound in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.